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INTRODUCTION
In Western countries, Gout is a common condition reported 
to affect around 1% of men with a reported male to female 
ratio between 7 and 9:1.1  The typical presentation is with in-
termittent, recurrent of mono- or oligoarticular inflammation 
characterised by very severe pain, however, a much less spe-
cific presentation with polyarticular chronic joint pain may 
occur, complicating the differential diagnosis.1
Dual Energy Computed Tomography (DECT) can identify 
specific elements and molecules such as iodine, calcium and 
uric acid, providing valuable new diagnostic information.2 
Imaging and identification of urate deposits provides a nov-
el, rapid, non-invasive and reliable method for the confirma-
tion of gout.3
In patients with or without a history of gout and a recent suspi-
cion for gouty arthritis, DECT has a marked diagnostic impact 
when hyperdense soft-tissue deposits are present.4A definitive 
diagnosis requires the direct identification of urate crystals in 
the joint and the exclusion of infection. Serum urate levels are 
frequently normal during attacks of acute gout, so reliance on 
urate level during acute attacks of gouty arthritis is not useful.5 
The classic plain radiographical signs such as well defined, 
punched out, periarticular erosions with overhanging edges, 
may not be seen until six or even more years after initial at-
tacks. MRI can be very useful, but is expensive and, like con-
ventional computed tomography, lacks specificity.6
Ultrasonography can be useful if the classic features of gout 
are present, being low cost, no radiation exposure, easy 
availability, and the ability to combine it with aspiration. 
However, it requires an experienced sonographer and high-
resolution equipment.7 Since none of these imaging modali-
ties can specifically identify the chemical composition of 
uric acid, a specific display algorithm based on the chemical 
composition of uric acid by dual-energy CT (DECT) scans is 
useful as an accurate imaging tool for gout.8
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Results: Seven case studies are presented where an unclear clinical presentation was successfully diagnosed with the use of 
DECT.
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The colour-coded information of the urate deposits in DECT 
scans allows for a computer-automated procedure to measure 
the volume of each clinical or subclinical tophus, which can 
then be summed to produce a total volume of urate deposi-
tion in peripheral joints of a given patient. Thus, DECT scans 
also carry several potential advantages as a follow-up imag-
ing tool over MRI, which was recently evaluated to quantify 
tophus size. These advantages include a lower cost (~1/6), a 
shorter scan time (~15 min for all peripheral joints), simul-
taneous scanning of multiple joints, obvious colour-differen-
tial display of crystals and minimal influence of positioning. 
Furthermore, the MRI volume measurement of tophus size 
involves the manual tracing of consecutive MR images.6
The potential applications of DECT also include establish-
ing the extent of gout by identifying subclinical intra- and 
extra-articular tophi, evaluation of nodular lesions, diagnos-
ing the concurrent presence of gout in patients with other 
arthropathies, identifying urate deposits in challenging and 
atypical anatomical sites of gout, understanding the anatomi-
cal distribution of the disease and monitoring the response to 
treatment through measurement of individual tophus volume 
and total tophus burden. Of note, OMERACT has proposed 
tophus regression as a core domain for outcome measures in 
chronic gout.9
The obvious colour display and three-dimensional volume-
rendered imaging of the disease allow information to be eas-
ily and communicated to clinicians and patients.
The radiation exposure of DECT for peripheral joint imag-
ing is minimal. It is estimated that the DECT radiation dose 
is 0.5 mSv of dose per scanned region and the total amount 
for all peripheral joints per patient ranges from 2 to 3 mSv, 
which is similar to the annual global per caput average dose 
due to natural radiation sources (2.4 mSv).10
Furthermore, the target image areas for gout are radio-insen-
sitive peripheral joints, and the vast majority of patients with 
gout are predominately middle-aged or elderly men, which 
supports a minimal risk of radiation associated with this po-
tential modality for gout at a practical level.10
DECT scans are possible in patients with severely impaired 
renal function. Usually, the two scan-energies are set to 
140kV and 80 kV. Based on these two imaging series, differ-
ent crystals with different absorption characteristics can be 
distinguished using several commercially available software 
modalities. These software tools allow for colour coded dis-
crimination of urate crystal deposits as well as several other 
crystal types. DECT can serve as a problem-solving tool in 
the presence of challenging clinical presentations.11
Aim
To establish the effectiveness of the Dual Energy Computed 
Tomography in the identification of gout in patients with 
complex presentations where the diagnosis is not clear.
Method
This is a gout diagnosis quality improvement audit. This re-
port is based on the review of seven patients records where 
DECT at 140 kV and 80kV was used to image patients where 
the clinical diagnosis was unclear. All possible patient iden-
tifiers were removed, with only gender and age was used. 
Patients verbal approvals were taken to use their pictures in 
this report.
RESULT AND DISCUSSION
Case report-1: A 74-year-old male, known case of chronic 
gout on Allopurinol. His co-morbidities were atrial fibrilla-
tion, hypertension and osteoarthritis. This patient presented 
with increasing pain/swelling in hands particularly the PIPs 
of both middle fingers that were slightly tender with nodu-
lar swellings over PIP and DIP. Uric acid was normal. The 
patient was anxious regarding his management and the pres-
ence of these nodular swellings. He thought that a change of 
management or increase in the Allopurinol dose is required. 
It was felt that his pain was due to a degenerative process 
rather than gout. CT dual-energy confirmed the complete 
absence of any urate crystals in the hands. We concluded 
that his chronic pain is caused mainly by the degenerative 
process. Management focused on physical therapy and the 
continuation of the same medications.
Case Report 2: A 54-year-old female was referred by her 
general practitioner with a history of Left foot pain on/off 
with swelling and redness. Her father and brother both have 
gout and she was very anxious that her symptoms are due 
to gout. On investigations her autoimmune screen including 
anti-CCP and ACE is negative, uric acid was normal. X-rays 
were unremarkable. DECT showed no evidence of any crys-
tal deposition providing reassurance to the patient. She was 
advised physical therapy and occasional NSAID. 
Case report 3: A 47-year-old female, known case of Fi-
bromyalgia, irritable bowel syndrome and gall stones. She 
was referred for painful toes in addition to fatigue due to 
fibromyalgia by her doctor. Examination revealed second 
toe classic dactylitis with tenderness but no other features 
of Spondylo-arthropathy. Her blood showed, ESR: 25 mm/
Hr, CRP: 2mg/L, Uric Acid 512µmol/L. DECT revealed 
urate crystals in the second MTPJ. No crystals seen around 
1st MTPJ and no erosive changes. She was advised to lose 
weight and pharmacological therapy was considered. 
Case report 4: A64-year-old male, known case of psoriatic 
arthritis and osteoarthritis, complained of severe hand and 
knee pains interfering with his job for the past 6 months. 
Clinically, he had mild to moderate tenderness in relevant 
joints, and could not make a full fist. X-ray showed promi-
nent degenerative in knees and hands but no erosions. Ultra-
sound (US) showed MCPJ synovitis but no clear underlying 
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aetiology. DECT confirmed the presence of uric acid crystals 
within flexor hand and proximal tendons corresponding clin-
ically with areas of tenderness. Pharmacological treatment 
was commenced, and he achieved considerable relief.
Case report 5: A 50-year-old male, drinking 35 units of al-
cohol weekly, was admitted to Hospital for left ankle pain 
and swelling. No crystals or infection in the synovial fluid. 
Uric acid level was 474µmolL-1 and autoimmune tests were 
negative. Examination revealed second MTPJ swelling but 
no findings in the ankle or big toes. 
DECT confirmed urate crystals in the second toe, Achilles 
tendon insertion; peroneal tendons and tibiofibular syndes-
mosis established the diagnosis of gout (Figure 1).
Figure 1: DECT image showing green coloured uric acid de-
posits in the second toe, Achilles tendon insertion, peroneal 
tendons and tibio-fabular syndesmosis 
Case report 6: A 72-year-old female patient presented 
with sudden swelling of MCPJs and proximal phalanges 
in all digits except the thumbs. Examination revealed, mild 
redness, no other signs of inflammation. The patient was 
extremely concerned, as she had a probable previous di-
agnosis of gout. Her uric acid level was highly elevated 
at 586µmolL-1, autoimmune screen was negative. US re-
ported fatty tissue with an unusual pattern of deposition. 
DECT confirmed the unusual fatty deposition and distribu-
tion, ruled out tophi, tumours or nodules. Patient was reas-
sured that the swellings were not gout related and the latter 
should be treated independently. 
Case report 7: A 74-year-old male, known case of gout on 
Allopurinol 300 mg, continued drinking alcohol around 60 
units weekly. He presented with moderate feet pain in both 
feet for >12 months. On examination he has bilateral MTPJ 
swelling and tenderness. His ESR was 8mm/Hr, CRP was 
26mg/L, autoimmune screen including Anti-CCP is negative 
and uric acid is normal at 218µmol/L. Intermittent oral ster-
oids helped his symptoms. DECT showed the presence of 
urate crystals around the MTPJs, mid and hindfoot and ankle 
tendons confirming the diagnosis of gout (Figure 2).  
Figure 2: DECT image showing the presence of urate crystals 
seen as green spots around MTPJ’s, midfoot, hindfoot and an-
kle tendons.
CONCLUSION
In straightforward cases where there is a typical clinical pic-
ture of acute arthritis where septic arthritis is the main differ-
ential diagnosis against crystal arthropathy, joint aspiration 
showing the presence of negatively birefringent monosodi-
um urate crystals, gout would be straightforward to confirm 
and manage. However, in difficult situations like excessive 
swelling of peripheral soft tissue and the absence of accessi-
ble fluid or tophus, there is a need for a specific and sensitive 
imaging tool. All our cases posed a diagnostic dilemma that 
needed confirmation, DECT was very useful to confirm or 
refute gouty arthritis. In our small case series, DECT, helped 
us to exclude the diagnosis of gout in cases 1,2 and 6, where-
as in the remaining cases, gout was confirmed.
When the clinical presentation is unclear, DECT is a non-
invasive, valuable, underutilised investigation that can estab-
lish the diagnosis of gout particularly when other arthritic 
conditions are present moreover it may rule out gout as a 
cause of the inflammatory process.
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